help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van den Aardweg, J. G.
Right arrow Articles by Karemaker, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van den Aardweg, J. G.
Right arrow Articles by Karemaker, J. M.
Am. J. Respir. Crit. Care Med., Volume 165, Number 8, April 2002, 1041-1047

Influence of Chemoreflexes on Respiratory Variability in Healthy Subjects

Joost G. Van den Aardweg and John M. Karemaker

Department of Physiology, Academic Medical Center, Amsterdam; and Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The background of this study was the hypothesis that respiratory variability is influenced by chemoreflex regulation. In search for periodicities in the variability due to instability of the respiratory control system, spectral analysis was applied to breath-to-breath variables in 19 healthy subjects at rest. During room-air breathing, coherent oscillations in end-tidal CO2 (PETCO2) and mean inspiratory flow (VI/TI) were found in 15 subjects with frequencies mostly below 0.15 cycles per breath. Coherent oscillations in PETCO2 and VI/TI were expressed by gain (0.13 to 0.34 L/second · kPa) and phase (-170° to +8°). The oscillations in VI/TI were in phase with inspiratory volume (VI). A model that describes the effects of chemoreflex feedback to noise in the system could explain these gains and phases, whereas a model without chemoreflex could not. During 100% O2 breathing, only eight subjects had coherent oscillations in PETCO2 and VI/TI. The coherent oscillations in PETCO2 and VI/TI were interpreted as a manifestation of chemoreflex activity. We conclude that respiratory variability is not a random process but contains information on chemoreflex properties, such as the chemoreflex gain. The analysis of respiratory variability therefore provides a new tool to study the action of the chemoreflexes without application of external stimuli.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Keywords: chemoreceptors; respiratory variability; spectral analysis

Is the normal variability of respiratory parameters from breath-to-breath a random process? This would imply that, for example, inspiratory volume (VI) or inspiratory and expiratory time (TI and TE, respectively) are independent of previous breaths. However, due to the circulatory delay from the lungs to the systemic arteries, an "accidental" change in VI causes a change in arterial PO2 and PCO2 that only becomes manifest during the following breaths at a normal breathing frequency (1, 2). An adaptation of VI to such a change therefore inevitably leads to a dependency between successive breaths. Conversely, purely random variability of VI implies that VI does not take part in the feedback control of PaO2 and PaCO2 through the chemoreflexes.

Several authors have found evidence for a nonrandom breath-to-breath variability of respiratory parameters in the normal steady state (3-5). Significant (auto)correlations have been found between successive values of VI, TI, and TE (4, 6). Specific variability patterns have also been found, mainly in the form of subtle oscillations with a cycle time of approximately 25 seconds to more than 3 minutes (6-10). Clear periodic breathing is seldom observed in healthy subjects during wakefulness (3, 7, 11, 12), but often occurs during sleep or at high altitude (13, 14). The cause of frank periodic breathing like Cheyne-Stokes breathing in cardiac failure is probably an instability of the chemoreflex-feedback control system (15- 17). It has been supposed that spontaneous changes in breathing pattern can induce (dampened) oscillations due to chemoreflex feedback in healthy subjects as well (8, 18, 19).

The aim of the present study was to derive information on respiratory regulation from the normal breathing pattern in the steady state. The hypothesis was that because of the delays and time constants of the chemoreflexes, continuous regulation tends to induce oscillations in ventilatory drive (represented by mean inspiratory flow, VI/TI) with a certain coherency with oscillations in end-tidal PCO2 (PETCO2). To identify such oscillatory components and their mutual relationships, power and cross-spectral analysis was applied to breath-to-breath respiratory variables in 19 healthy subjects at rest. To test the hypothesis that the features of coherent oscillations in PETCO2 and VI/TI are compatible with the characteristics of chemoreflex-feedback regulation, experimental spectra were compared with theoretical spectra derived from a chemoreflex model. The breathing pattern was also analyzed during 100% O2 breathing to estimate the contribution of the peripheral chemoreflex (20).

    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects and Measurements

Nineteen healthy nonsmoking medical students were studied with a history free of cardiopulmonary disease and normal physical examination (9 male and 10 female, aged 23 ± 3 years, body mass index 22.2 ± 3.1 kg/m2, mean ± SD). The hospital ethical committee approved the protocol. Informed consent was obtained. The subjects knew which measurements were performed. To prevent "conscious" breathing, they were told that the study involved blood pressure regulation. They sat in a comfortable chair in a quiet room and breathed through a cushion-sealed face mask fitted with elastic bands around the head (dead space ~ 70 ml).

A Lilly type pneumotachograph (Siemens pressure transducer, Munich, Germany) was connected to the mask and hung with an elastic cord to the ceiling. A two-way nonrebreathing valve (S and W, Copenhagen, Denmark) was connected to the pneumotachograph. The inspiratory limb was connected to a stopcock (through a 1-m spirometer tube) which could be switched from room air to 100% O2 from a 100 L bag. The stopcock was hidden behind a curtain so that the subject did not know which gas was inspired. The experiments began between 9:00 and 10:00 A.M. Recordings started after a 5-minute acclimatizion period. There were two episodes of 30 minutes with more than 5 minutes in between, performed in a random order, during which the subjects breathed either air or 100% O2 (starting when end-tidal PO2 exceeded 85 kPa). Also measured were PO2 and PCO2 in the facemask (partial pressures in dry air, Centronic 200 MGA mass spectrometer, Croydon, United Kingdom), arterial O2 saturation (SaO2, Ohmeda Biox ear pulse oximeter, Madison, WI), finger arterial pressure (Finapres BMI-TNO, Amsterdam, Netherlands) and a single-channel chest-lead ECG. All signals were recorded on a Bell and Howell T4 recorder (Durham, NC) with airflow, ECG and blood pressure on FM channels and the other signals on a direct record channel using a Kayser Threde K 1180 pulse code modulator (Munich, Germany). The frequency response was 0-625 Hz for FM channels and 0-105 Hz for pulse code modulated channels.

After digitizing at 200 Hz, breath-to-breath variables were derived from the pneumotachogram. To reduce a disproportionate influence of isolated deep breaths, the values of breaths with VI greater than 1.5 times the mean of adjoining breaths were linearly interpolated. PETCO2 and end-tidal PO2 (PETO2 ) were derived as the maximal PCO2 (and minimal PO2) during the last second of expiratory flow. Beat-to-beat mean blood pressure and R-R interval were derived from the finger pressure and ECG. Means and SDs of each variable were compared between air and O2 breathing (paired t test) with a prior log-transformation of SDs of ventilatory variables (10). Group values are means ± SEM.

Spectral Analysis

Power spectra. In search of oscillatory components in respiratory variability, power spectra were derived for each variable. The underlying concept of spectral analysis is that each variability pattern can be written as the sum of a number of oscillations with a certain frequency, amplitude and phase (21). The power is proportional to the squared amplitude of such an oscillation. The reason to use power instead of amplitude is that the mean power, as it is defined here, equals the variance. Thus, the power spectrum shows the extent to which oscillation at each frequency contributes to the overall variance. For a variable that changes from breath to breath (with breath number M), the oscillation frequencies (fm) are in cycles per breath. For example, when fm is 0.25 cycles per breath, the oscillation has a cycle duration of four breaths. In a series of M breaths, only a limited number of frequencies can be discerned. The slowest oscillation has a frequency of 1/M cycles per breath. The other frequencies are all multiples of this basic frequency. The highest possible frequency is 0.5 cycles per breath.

Cross spectra. With spectral analysis it is also possible to "dissect" two variables into oscillatory components and to analyze the relationship between these oscillations. Figure 1 shows an example of two oscillations that occur in the breath-to-breath variability of PETCO2 and VI/TI. The cycle duration is 12 breaths (fm is 0.083 cycles per breath). Both oscillations have a constant amplitude here, 0.36 kPa for PETCO2 and 0.10 L/second for VI/TI. The relationship between the oscillations is expressed by the gain and phase. The gain from PETCO2 to VI/TI (GC,VI/TI) is the ratio of the amplitude of VI/TI to the amplitude of PETCO2. In the example, GC,VI/TI = 0.10/0.36 = 0.28 L/second · kPa. The phase from PETCO2 to VI/TI (phiC,VI/TI) is defined as negative when a maximum in PETCO2 occurs less than half a cycle before a maximum in VI/TI. In the example, a maximum in PETCO2 occurs four breaths before a maximum in VI/TI, so that phiC,VI/TI-(4/12) · 360° = -120°. When the relationship between PETCO2 and VI/TI is linear, an increase in the amplitude of PETCO2 is accompanied by a proportional increase in the amplitude of VI/TI. A perfectly linear relationship between two oscillations is completely described by gain and phase. In reality, some "noise" always occurs so that an exact determination of gain and phase is never possible. The gain and phase can, however, be estimated with a certain level of confidence, depending on the number of degrees of freedom of the data and the degree of linearity of the relationship. For the relationship between PETCO2 and VI/TI, the degree of linearity is described by the squared coherency k2C,VI/TI which ranges from zero (no linear relationship) to one (perfectly linear relationship). The (estimated) squared coherency can be interpreted as a squared correlation coefficient for variations with a specific frequency. Similarly, the estimated gain can be seen as a frequency-specific linear regression coefficient. The squared coherency, gain, and phase spectra describe these estimates for all frequencies that occur within the variability of the two variables. Together they are derived from the "cross spectrum" (21). Cross-spectral analysis thus amounts to a linear regression in the frequency domain.


View larger version (20K):
[in this window]
[in a new window]
 
Figure 1.   Example of oscillations in breath-to-breath end-tidal PCO2 (PETCO2) and mean inspiratory flow (VI/ TI) with a cycle duration of 12 breaths. The phase from PETCO2 to VI/TI (phiC,VI/TI) is -120 °.

Cross spectra were determined for PETCO2 and VI/TI, VI/TI and VI, VI and TE, and for PETCO2 and PETO2. We were particularly interested in the relationship between PETCO2 and VI/TI as these variables are related to the input and output of the chemoreflexes (1, 22, 23). "Coherent oscillations" in PETCO2 and VI/TI were defined as oscillations with (1) a significant coherency between PETCO2 and VI/TI and (2) a power of both PETCO2 and VI/TI that is significantly higher than the mean power.

A trend was removed from the data to reduce the influence of very low frequencies. The data were multiplied by a Tukey window and transformed from the "breath number" (m) domain to the "frequency" (fm) domain with the discrete Fourier transform (21). The spectra were smoothed by a triangular running window (width ~ 0.01 cycles per breath) to increase the number of degrees of freedom of each spectral estimate (24). The power spectral estimate was considered as significantly higher than the mean power when the lower limit of the 90% confidence interval was higher than the mean. The centroid frequency, defined as the frequency below which 50% of the power occurs, was determined for each variable (6). The expected centroid frequency for white noise is 0.25 cycles per breath (21). The centroid frequencies were tested for deviation from white noise with the Kolmogoroff-Smirnov test (21). Cross-spectral estimates were considered significant if the lower limit of the 90% confidence interval of the squared coherency was larger than 0.3 (21).

To calculate group averages for cross-spectral estimates, the frequencies between zero and 0.5 cycles per breath were divided into bins of 0.01 cycles per breath. The reason was that the frequencies (multiples of 1/M) differed between the subjects because of differing M. For each subject, the mean cross-spectral estimate for each frequency bin was derived, only including cross-spectral estimates with a significant coherency. These mean values were used to calculate the group means. Coherent oscillations in PETCO2 and VI/TI were compared between air and 100% O2 breathing as to occurrence (25) and oscillation frequency (Wilcoxon rank sum test). p < 0.05 was taken as significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Air Breathing

The subjects breathed regularly during the experiments without falling asleep. Only in Subject 19 the last 120 breaths were discarded because of relative hyperventilation. Group averages for breath-to-breath means and SDs are given in Table 1. The steady state was confirmed by the relatively small SDs of blood pressure and R-R interval. SaO2 was above 94% during air breathing. The number of breaths was 442 ± 25, of which 1.3 ± 0.3% were interpolated as sighs.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1

 MEANS AND STANDARD DEVIATIONS OF RESPIRATORY AND CIRCULATORY VARIABLES

In the example of Figure 2, periodicities in the breath-to-breath variability are not obvious. Neither is there a clear relationship between changes in PETCO2 and VI/TI. Only the variations in PETCO2 and PETO2 seem to be related and appear out-of-phase. The corresponding power spectra of PETCO2 and VI/TI are shown in Figure 3. The power of both variables was concentrated at low frequencies (below 0.20 cycles per breath). This also appears from the low centroid frequencies in most subjects (Table 2).


View larger version (23K):
[in this window]
[in a new window]
 
Figure 2.   Breath-to-breath variability in Subject 4 during air breathing. VI/TI, mean inspiratory flow; PETCO2 and PETO2, end-tidal PCO2 and PO2.


View larger version (23K):
[in this window]
[in a new window]
 
Figure 3.   Power spectra of end-tidal PCO2 (P, dotted line) and mean inspiratory flow (PVI/TI, continuous line) as a function of frequency in cycles per breath (from Subject 4). Bold lines indicate the part of the spectra where the relationship between oscillations in PETCO2 and VI/TI is coherent.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2

 CENTROID FREQUENCIES FOR BREATH-TO-BREATH VARIABLES

The bold lines in Figure 3 represent the part of the power spectra that meet the criteria for coherent oscillations in PETCO2 and VI/TI. This occurs at a small peak in both spectra at approximately 0.09 cycles per breath, corresponding to a cycle of about 11 breaths or roughly 50 seconds, as the mean breath duration (TTOT) was 4.4 seconds for this subject. Coherent oscillations in PETCO2 and VI/TI were found in 15 of the 19 subjects. Figure 4 shows the averaged gain and phase for coherent oscillations, most of which occurred below 0.15 cycles per breath. The phase phiC,VI/TI was mostly negative, on the average about -90°. This means that a maximum in the oscillation in PETCO2 occurred less than half a cycle before a maximum in VI/TI (as in Figure 1). Table 3 gives a summary of the other cross-spectral estimates at the frequencies of coherent oscillations in PETCO2 and VI/TI. It shows that in 14 of the 15 subjects, the oscillation in VI/TI was tightly coupled to an in-phase oscillation in VI. Almost every coherent oscillation in PETCO2 and VI/TI was accompanied with an out-of-phase oscillation in PETO2.


View larger version (20K):
[in this window]
[in a new window]
 
Figure 4.   Gain (GC,VI/TI) and phase (phiC,VI/TI) for coherent oscillations in PETCO2 and VI/TI during air breathing. Bold lines are group means and thin lines are means ± SD for each frequency bin of 0.01 cycles per breath. Only significant gain and phase estimates are included (from 15 subjects with coherent oscillations).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 3

 CROSS-SPECTRAL ESTIMATES FOR COHERENT OSCILLATIONS IN END-TIDAL CO2 AND MEAN INSPIRATORY FLOW

100% O2 Breathing

Means and SDs of breath-to-breath variables during air breathing are compared with 100% O2 breathing in Table 1. The number of breaths was 425 ± 12 with 1.5 ± 0.4% sighs. The smaller number of breaths compared with air breathing was due to the criterion that PETO2 had to exceed 85 kPa. In Subject 1 a reliable pneumotachogram was not obtained. The mean VI was significantly higher than during air breathing (difference 0.089 ± 0.028 L), while the mean PETCO2 was significantly lower (difference -0.21 ± 0.04 kPa). None of the respiratory variables showed a significant difference in breath-to-breath SD between air and O2 breathing (Table 1). The centroid frequencies were not significantly different from air breathing. Coherent oscillations in PETCO2 and VI/TI were only found in eight subjects, significantly less often than during air breathing (p < 0.01, Table 3). The coherency occurred at a mean frequency of 0.055 cycles per breath (range 0.023-0.096, not significantly different from air breathing).

Model Simulation

The spectra can be interpreted by showing that they are compatible with a supposed mechanism. This approach is strengthened when the spectra cannot be explained by alternative hypotheses. It is, however, difficult to deduce, even from a simple hypothesis, what the spectra would precisely look like. We therefore expressed our hypotheses in mathematical equations and algebraically derived the spectra from these equations. This also improves the insight into the way the various physiologic mechanisms can influence the spectra.

The main hypothesis was that the variability of PETCO2 and VI/TI is influenced by chemoreflex feedback. Suppose that these variables would, instead, vary at random from breath to breath according to a normal distribution with a given mean and variance. Then the variability would contain all possible oscillations to the same extent (if the series of breaths is infinitely long). The power would thus be constant as a function of frequency, equal to the variance ("white noise") (21). If, however, chemoreflexes continuously react to such noise, the noise becomes filtered so that the power becomes significantly higher or lower than the mean power at particular frequencies. Such a filter mechanism can also influence the relationship between otherwise independent variables, resulting in a significant coherency.

Because breath-to-breath variability is a discontinuous process in the course of time, we used "discontinuous" equations (difference equations). The input to the model is white noise, which is mainly filtered by the chemoreflex. Provided that the difference equations are linear, the resulting spectra can be derived in a straightforward manner (21). We therefore applied linearized equations for the chemoreflex response to changes in PETCO2 and for the effects of ventilation on PETCO2. This is supported by the relatively high coherencies between PETCO2 and VI/TI (Table 3). The model is analogous to earlier models of hemodynamic variability (24, 26).

Description of the Chemoreflex-Feedback Model

A schematic of the model is shown in Figure 5. The variability is "driven" by two sources of noise, E1 and E2. The noise E1 is noise that directly affects PETCO2, such as changes in breathing frequency, cardiac output, or mixed venous PCO2. The noise E2 has a direct influence on VI/TI and can be due to any changes in respiratory drive that are not caused by chemoreflex feedback (22, 27). It is assumed that the chemoreflex response only consists of an increase in VI/TI after an increase in PETCO2 (1, 22). It is assumed that a change in VI/TI leads to a proportional change in VI. The variability of TI is neglected, so that TI is considered equal to the mean value (TI). In the online data supplement (Section A) it is shown that this implies that the ratio of a change in VI to a change in VI/TI equals TI . The constant c2 in Figure 5 expresses the ventilatory influence of VI on PETCO2. The minus sign for c2 indicates that an increase in VI leads to a decrease in PETCO2. The constant c1 expresses the dependency of PETCO2 on the previous breath, mainly because of the buffer of the FRC.


View larger version (14K):
[in this window]
[in a new window]
 
Figure 5.   Schematic of the chemoreflex-feedback model. The variability of PETCO2 and VI/TI is driven by two sources of noise, varepsilon  1 and varepsilon  2. The noise is filtered by the chemoreflex-feedback loop and the dependency of PETCO2 on the previous breath. c1, coefficient of the dependency of PETCO2 on the previous breath; c2, coefficient of the influence of VI on PETCO2; TI , mean TI.

Development of respiratory oscillations by chemoreflex feedback. The supposed principle of the development of respiratory oscillations by chemoreflex feedback has been described by a number of authors (e.g., 14, 15, 16, 17, 18, 28). Essential is the delay of the response. Figure 6 shows the simplest version of the present model that can explain the occurrence of respiratory oscillations. The dependency of PETCO2 on the previous breath is neglected here. It is assumed that the chemoreflex response to an "accidental" increase in PETCO2 (arrow in Figure 6) leads to an increase in VI/TI after a delay of two breaths. The correction (a decrease in PETCO2) thus occurs two breaths after the initial increase in PETCO2. This decrease in PETCO2 in turn leads to a corrective increase in PETCO2 after two breaths, and so on. The result is a dampened oscillation in PETCO2 and VI/TI with a cycle duration of four breaths, or a frequency of 0.25 cycles per breath. The cycle duration increases if the respiratory drive persists during following breaths ("short-term potentiation") (1, 29) or the dependency of PETCO2 on the previous breath increases.


View larger version (14K):
[in this window]
[in a new window]
 
Figure 6.   Dampened oscillation in PETCO2 and VI/TI caused by delayed chemoreflex feedback after an accidental increase in PETCO2. Open circles, breath-to-breath PETCO2 (left axis), arrow indicates accidental increase in PETCO2; closed circles, VI/TI (right axis).

Power and Cross-Spectra according to the Model

When the situation of Figure 6 is extended to repetitive accidental disturbances in PETCO2, multiple dampened oscillations are generated in PETCO2 and VI/TI. This implies a filter mechanism that selectively amplifies random disturbances in PETCO2 around a "resonance" frequency. Figure 7 shows an example of a purely peripheral chemoreflex model. Without chemoreflex, the two sources of noise would initially result in white noise in PETCO2 with a constant power (see Figure 7A for c1 = 0). Due to the dependency of PETCO2 on the previous breath, the power is amplified below ~ 0.20 cycles per breath and suppressed at higher frequencies ("low-pass filter", see Figure 7A for c1 = 0.5). Chemoreflex feedback further amplifies the power around 0.12 cycles per breath and suppresses the rest of the spectrum (resonance or band-pass filter phenomenon). The power of VI/TI also shows a resonance around this frequency (open circles in Figure 7). For lower frequencies, the power of VI/TI is also amplified, as opposed to PETCO2. These opposing effects of chemoreflex activity reflect an adequate action of the reflex, which tends to suppress spontaneous changes in PETCO2 by increasing the variability of VI/TI. Without chemoreflex, the total power of VI/TI would be considerably lower.


View larger version (31K):
[in this window]
[in a new window]
 
Figure 7.   Hypothetical spectra for the model without chemoreflex (dotted lines) or with only a peripheral chemoreflex (continuous lines). PC, power of PETCO2; c1, coefficient of the dependency of PETCO2 on the previous breath; PVI/TI, power of VI/TI; k2C,VI/TI, squared coherency between PETCO2 and VI/TI; GC,VI/TI and phiC,VI/TI, closed-loop gain and phase from PETCO2 to VI/TI; Gchi and phichi , open-loop chemoreflex gain and phase from PETCO2 to VI/TI; G0 and phi0, gain and phase from PETCO2 to VI/TI for the situation without chemoreflex; Sp, peripheral chemoreflex sensitivity (in L/second · kPa). Open circles refer to the resonance frequency.

The squared coherency (k2C,VI/TI) is maximal at the resonance frequency (Figure 7C). Without chemoreflex, the coherency would be low for all frequencies. The relationship would then exclusively be due to the ventilatory influence of VI/TI on PETCO2. The coherency would thus be determined by the contribution of noise in VI/TI to the noise in PETCO2.

The gain (GC,VI/TI) in Figure 7D refers to the "closed-loop" situation (as in Figure 6).The chemoreflex gain (Gchi ) is the "open-loop" gain from PETCO2 to VI/TI (neglecting the ventilatory influence of VI/TI on PETCO2). When the frequency is zero, Gchi equals the peripheral chemoreflex sensitivity (Sp). At the resonance frequency, GC,VI/TI is almost equal to Gchi (only slightly higher). Without chemoreflex, the gain would be low (G0).

Figure 7E shows that the closed-loop phase phiC,VI/TI is closely related to the open-loop chemoreflex phase phichi at the resonance frequency. The phase phichi is almost linearly related to the frequency, which is mainly determined by the chemoreflex delay. Without chemoreflex, phiC,VI/TI would lie approximately in the range between -150° and -170° (phi0). A more extensive analysis is given in Section D of the online data supplement. An alternative model is also analyzed where short-term potentiation of respiratory drive occurs after other stimuli (27, 30).

Interpretation of Experimental Data with the Model

1. The variability of PETCO2, VI/TI, and VI is not random, but is subject to low-pass filter mechanisms. Possible filter mechanisms are the dependency of PETCO2 on the previous breath, chemoreflex feedback, and short-term potentiation of respiratory drive.

2. Chemoreflex feedback can explain coherent oscillations in PETCO2 and VI/TI. The reflex delay causes resonance at a frequency where the squared coherency is high. This frequency is mainly determined by the reflex delay, but shifts to lower frequencies when the dependency of PETCO2 on the previous breath becomes more important. Experimentally observed frequencies are compatible with peripheral chemoreflex feedback, with an unknown contribution of the central response. Gains and phases are compatible with the chemoreflex model.

3. Chemoreflex feedback through central chemoreceptors can explain coherent oscillations in PETCO2 and VI/TI during 100% O2 breathing.

4. Without chemoreflex, coherent oscillations in PETCO2 and VI/TI are unlikely as there is no resonance at a specific frequency, and the expected coherency is low. The corresponding gain is low compared with experimental data. The phase is confined to a range from about -150° to -170° and cannot explain most experimental values.

5. Short-term potentiation of VI/TI without chemoreflex-feedback can explain the relatively high coherencies and gains between PETCO2 and VI/TI below approximately 0.08 cycles per breath. The phase is, however, equal to the situation of conclusion 4.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Interpretation of Coherent Oscillations in End-Tidal CO2 and Mean Inspiratory Flow

The coherent oscillations in PETCO2 and VI/TI that were found in 15 subjects were interpreted as the result of spontaneous "noise" in the respiratory system, which is filtered by the chemoreflex. Sighs, coughs, and changes in CO2 production or cardiac output may all add to such noise. This mechanism was proposed by Modarreszadeh and colleagues (8), who found that the highest power of PETCO2 and minute volume occurred below 0.10 cycles per breath in quietly breathing subjects. They applied an end-tidal CO2 buffering technique which allowed an artificial reduction of the power of PETCO2 below 0.10 cycles per breath (under hyperoxic conditions). The consequence was a significant reduction in the power of minute volume. This is the most convincing evidence that a considerable part of the ventilatory variability can result from a response to fluctuations in PETCO2. Another indication that part of the respiratory variability is due to chemoreflex activity comes from a study in rats where the variability of phrenic nerve activity was studied (31).

The frequencies of coherent oscillations were mostly below 0.20 cycles per breath. Most of these frequencies could be explained by the delays of the peripheral chemoreflex, with a shift to lower frequencies due to the dependency of PETCO2 on the previous breath. The cycle durations were 5 to 12 breaths (~ 20-60 seconds). This contrasts with the cycle time of frank periodic breathing during high-altitude hypoxia, which is mostly 18 to 25 seconds (13, 32). A similar difference in cycle time has been observed between normoxia and isocapnic hypoxia (10). The "fast" periodic breathing during hypoxia is probably caused by peripheral chemoreflex activity as well (20). This does not preclude, however, a role for peripheral chemoreceptors in the development of the relatively "slow" oscillations in the present study. The model predicts a difference in cycle time between normoxia and hypoxia if hypoxia is considered as an "amplifier" of the peripheral chemoreflex sensitivity to PaCO2 (33). As explained in Section D.2.3 of the online data supplement (Figure E8), a shift to a shorter cycle time due to an increased chemoreflex sensitivity can be expected if there is a certain dependency of PETCO2 on the previous breath. In the model, it is actually this dependency that adds to the "slowness" of the respiratory system during normoxia. The contribution of the peripheral feedback loop in our study is further supported by the reduction of coherent oscillations by 100% O2. A contribution of the central feedback loop to the variability can also be expected below approximately 0.10 cycles per breath. However, because such slow oscillations can occur less often during a recording time of 30 minutes, the chance of finding them is smaller than for faster oscillations. The inhalation of 100% O2 has probably also altered the central drive, as suggested by the increased mean ventilation. This may be secondary to a reduction of the Haldane effect or a suppression of central hypoxic inhibition (34).

The squared coherency between PETCO2 and VI/TI has a double meaning here. First, it is a measure of linearity of the relationship between PETCO2 and VI/TI at a specific frequency, regardless of its physiologic interpretation. Second, according to the model, it is a direct estimate of the "loop gain" of the feedback system. The loop gain reflects the amplification in the feedback loop and is a major determinant of the tendency to oscillate (15). Other more indirect estimation procedures for loop gain have been described for pseudorandom CO2 inhalation (35) or transient changes in PETCO2 (16).

The model analysis revealed a close relationship between the closed-loop gain from PETCO2 to VI/TI and the open-loop chemoreflex gain for coherent oscillations. This makes an estimation of the chemoreflex gain possible during the steady state without additional stimulation (e.g., in sleep studies or during continuous monitoring in the ICU). We did not, however, compare this method with a standard technique. The approach is not essentially different from the analysis of dampened respiratory oscillations induced by spontaneous sighs (18), acute changes in inspiratory PCO2 (16), or pseudorandom CO2 stimulation (35). A drawback is that the facemask could have influenced the breathing pattern (12), although we did not find coherent oscillations in every subject. This probably depends on the ratio between the different sources of noise. The variability of arterial PO2 may also play a role because PETCO2 and PETO2 oscillated out-of-phase, so that an additive effect on peripheral chemoreceptors is possible (36).

The finding that the phase between VI/TI and VI was about zero for coherent oscillations (Table 3) indicates that VI/TI during a given breath was positively related to VI of the same breath. Because the gain of this relationship was about equal to the mean TI (see also Table 1), this could be explained by the model as a direct influence of changes in VI/TI on VI at a relatively constant TI. Apparently, there was no strong mechanism that counteracted the evoked changes in respiratory drive (VI/TI) by an adaptation of TI (5). The relationship between VI and TE was relatively weak, with a rough clustering of the phase between VI and TE around zero (Table 3). This may be related to a mechanism that lengthens TE in response to high VI, although the Hering-Breuer reflex is probably only operating for VI above 1.2 L (37). Anyway, a zero phase between VI and TE argues against a strong influence of chemoreflexes on TE, because chemoreflexes would simultaneously increase VI/TI (and thus increase VI) and shorten TE (23).

Modeling of Chemoreflex Feedback

A number of mathematical models have already been implemented to explain periodic breathing from chemoreflex characteristics in heart failure or during hypoxia (e.g., 15, 16, 17). Several models also give a good description of dampened oscillations after sudden changes in the system such as a sigh or an increase in inspiratory CO2 (16, 18, 35). The present model is actually a simplification of existing models where the relationship between respiratory variables is described from breath to breath (18, 35, 38, 39). What is new is the analytical derivation of power and cross-spectra from such simplified linear difference equations. The reason to explore respiratory variability in the frequency domain is that the supposed linear interactions constitute a time-invariant filter to noise in the system. We tried to explain the spectral features by a model as simple as possible. The major advantage is that this gives insight into the main mechanisms of the variability. A drawback is that nonlinear interactions can occur that are not always well approximated by a linear model. For example, a highly variable TTOT would change the chemoreflex response in terms of number of breaths, so that the response function becomes nonlinear. The same holds true for variations in chemoreflex sensitivity or cardiac output. The ventilatory influence of VI/TI on PETCO2 is probably more nonlinear for larger variations (40).

In conclusion, we found that coherent oscillations in PETCO2 and VI/TI occur in the normal respiratory variability. These oscillations could be explained as a chemoreflex response to spontaneous changes in the respiratory system, indicating that respiration is continuously adjusted by the chemoreflexes so that the respiratory variability is not random. Previously, the function of the chemoreflexes was mostly studied with external stimuli (e.g., inhaled CO2). While the response to such stimuli shows the capability of the reflexes to respond, the analysis of respiratory variability makes it possible to derive information on the actual performance of the chemoreflexes.

    Footnotes

Correspondence and requests for reprints should be addressed to J. G. van den Aardweg, M.D. Ph.D., Afdeling Longziekten 117, Medisch Centrum Alkmaar, P.O. Box 501, 1800 AM Alkmaar, The Netherlands. E-mail: j.g.vanden.aardweg{at}mca.nl

(Received in original form April 4, 2001 and accepted in revised form January 14, 2002).

This article has an online data supplement, which is accessible from this issue's table of contents online at www.atsjournals.org

Acknowledgments: The authors thank Wim Stok, M.Sci., for his valuable technical contribution to the study.

Supported by the University of Amsterdam.

    References
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1. Bellville JW, Whipp BJ, Kaufman RD, Swanson GD, Aqleh KA, Wiberg DM. Central and peripheral loop gain in normal and carotid-body resected subjects. J Appl Physiol 1979; 46: 843-853 [Free Full Text].

2. Cunningham DJC. A model illustrating the importance of timing in the regulation of breathing. Nature 1975; 253: 440-442 [Medline].

3. Priban IP. An analysis of some short-term patterns of breathing in man at rest. J Physiol (Lond) 1963; 166: 425-434 .

4. Tobin MJ, Yang KL, Jubran A, Lodato RF. Interrelationship of breath components in neighboring breaths of normal eupneic subjects. Am J Respir Crit Care Med 1995; 152: 1967-1976 [Abstract].

5. Newsom Davis J, Stagg D. Interrelationships of the volume and time components of individual breaths in resting man. J Physiol (Lond) 1975;245:481-498.

6. Jubran A, Grant BJB, Tobin MJ. Effect of hyperoxic hypercapnia on variational activity of breathing. Am J Respir Crit Care Med 1997; 156: 1129-1139 [Abstract/Free Full Text].

7. Lenfant C. Time-dependent variations of pulmonary gas exchange in normal man at rest. J Appl Physiol 1975; 22: 675-684 .

8. Modarreszadeh M, Bruce EN. Ventilatory variability induced by spontaneous variations of PaCO2 in humans. J Appl Physiol 1994; 76: 2765-2775 [Abstract/Free Full Text].

9. Hlastala MP, Wranne B, Lenfant CJ. Cyclical variations in FRC and other respiratory variables in resting man. J Appl Physiol 1973; 34: 670-676 [Free Full Text].

10. Jubran A, Tobin MJ. Effect of isocapnic hypoxia on variational activity of breathing. Am J Respir Crit Care Med 2000; 162: 1202-1209 [Abstract/Free Full Text].

11. Gillam PMS. Patterns of respiration in human beings at rest and during sleep. Bull Eur Physiopath Resp 1972; 8: 1059-1070 .

12. Van den Aardweg JG, Karemaker JM. Respiratory variability and associated cardiovascular changes in adults at rest. Clin Physiol 1991; 11: 95-118 [Medline].

13. Brusil PJ, Waggener TB, Kronauer RE, Gulesian P. Methods for identifying respiratory oscillations disclose altitude effects. J Appl Physiol 1980; 48: 545-556 [Abstract/Free Full Text].

14. Chapman KR, Bruce EN, Gothe B, Cherniack NS. Possible mechanisms of periodic breathing during sleep. J Appl Physiol 1988; 64: 1000-1008 [Abstract/Free Full Text].

15. Khoo MCK, Kronauer RE, Strohl KP, Slutsky AS. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 1982; 53: 644-659 [Abstract/Free Full Text].

16. Carley DW, Shannon DC. A minimal mathematical model of human periodic breathing. J Appl Physiol 1988; 65: 1400-1409 [Abstract/Free Full Text].

17. Longobardo GS, Cherniack NS, Fishman AP. Cheyne-Stokes breathing produced by a model of the human respiratory system. J Appl Physiol 1966; 21: 1839-1846 [Free Full Text].

18. Khoo MCK, Marmarelis VZ. Estimation of peripheral chemoreflex gain from spontaneous sigh responses. Ann Biomed Eng 1989; 17: 557-570 [Medline].

19. Jensen JI, Mosekilde E, Ward DS. A system dynamics model of human respiratory regulation. In: Whipp BJ, Wiberg DM, editors. Modelling and control of breathing. New York: Elsevier; 1983. p. 316-321.

20. Lahiri S, Hsiao C, Zhang R, Mokashi A, Nishino T. Peripheral chemoreceptors in respiratory oscillations. J Appl Physiol 1985; 58: 1901-1908 [Abstract/Free Full Text].

21. Jenkins GM, Watts DG. Spectral analysis and its applications. San Fransisco: Holden-Day; 1968.

22. Whitelaw WA, Derenne JP, Milic-Emili J. Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol 1975; 23: 181-199 [Medline].

23. Ledlie JF, Nielsen SG, Cherniack NS, Fishman AP. Effects of hypercapnia and hypoxia on phrenic nerve activity and respiratory timing. J Appl Physiol 1981; 51: 732-738 [Abstract/Free Full Text].

24. DeBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol 1985;253 (Heart Circ Physiol 22):H680-H689.

25. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell; 1987. 123-125.

26. Van den Aardweg JG, Van Steenwijk RP, Karemaker JM. A chemoreflex model of relation between blood pressure and heart rate in sleep apnea syndrome. Am J Physiol 1995;268 (Heart Circ Physiol 37): H2145-H2156.

27. Swanson GD, Ward DS, Bellville JW. Posthyperventilation isocapnic hyperpnea. J Appl Physiol 1974; 37: 723-735 [Free Full Text].

28. Carley DW, Shannon DC. Relative stability of human respiration during progressive hypoxia. J Appl Physiol 1988; 65: 1389-1399 [Abstract/Free Full Text].

29. Georgopoulos D, Bshouty Z, Younes M, Anthonisen NR. Hypoxic exposure and activation of the afterdischarge mechanism in conscious humans. J Appl Physiol 1990; 69: 1159-1164 [Abstract/Free Full Text].

30. Benchetrit G, Bertrand F. A short-term memory in the respiratory centres: statistical analysis. Respir Physiol 1975; 23: 147-158 [Medline].

31. Khatib MF, Oku Y, Bruce EN. Contribution of chemical feedback loops to breath-to-breath variability of tidal volume. Respir Physiol 1991; 83: 115-128 [Medline].

32. Waggener TB, Brusil PJ, Kronauer RE, Gabel RA, Inbar GF. Strength and cycle time of high-altitude ventilatory patterns in unacclimatized humans. J Appl Physiol 1984; 56: 576-581 [Abstract/Free Full Text].

33. Honda Y, Tani H. Chemical control of breathing. In: Altose MD, Kawakami Y, editors. Control of breathing in health and disease. In: Lenfant C, editor. Lung biology in health and disease, Vol. 135. New York: Marcel Dekker; 2000. p. 41-88.

34. Holtby SG, Berezanski DJ, Anthonisen NR. Effect of 100% O2 on hypoxic eucapnic ventilation. J Appl Physiol 1988; 65: 1157-1162 [Abstract/Free Full Text].

35. Ghazanshahi SD, Khoo MCK. Estimation of chemoreflex loop gain using pseudorandom binary CO2 stimulation. IEEE Trans Biomed Eng 1997; 44: 357-366 [Medline].

36. Akiyama Y, Kawakami Y. Clinical assessment of the respiratory control system. In: Altose MD, Kawakami Y, editors. Control of breathing in health and disease. In: Lenfant C, editor. Lung biology in health and disease, Vol. 135. New York: Marcel Dekker; 2000. p. 251-287.

37. Iber C, Simon S, Skatrud JB, Halowald MW, Dempsey JE. The Breuer-Hering reflex in humans. Am J Respir Crit Care Med 1995; 152: 217-224 [Abstract].

38. Busso T, Liang PJ, Robbins PA. Breath-to-breath relationships between respiratory cycle variables in humans at fixed end-tidal PCO2 and PO2. J Appl Physiol 1996; 81: 2287-2296 [Abstract/Free Full Text].

39. Modarrheszadeh M, Kump KS, Chizeck HJ, Hudgel DW, Bruce EN. Adaptive buffering of breath-by-breath variations of end-tidal CO2 of humans. J Appl Physiol 1993; 75: 2003-2012 [Abstract/Free Full Text].

40. Chilton AB, Stacy RW. A mathematical analysis of carbon dioxide respiration in man. Bull Math Biophys 1952; 14: 1-18 .





This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
Y. Mebrate, K. Willson, C. H. Manisty, R. Baruah, J. Mayet, A. D. Hughes, K. H. Parker, and D. P. Francis
Dynamic CO2 therapy in periodic breathing: a modeling study to determine optimal timing and dosage regimes
J Appl Physiol, September 1, 2009; 107(3): 696 - 706.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. D. Mitsis, R. J. M. Governo, R. Rogers, and K. T. S. Pattinson
The effect of remifentanil on respiratory variability, evaluated with dynamic modeling
J Appl Physiol, April 1, 2009; 106(4): 1038 - 1049.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. G. van den Aardweg
Respiratory variability after opioids: see it happen
J Appl Physiol, April 1, 2009; 106(4): 1029 - 1030.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
K. T. S. Pattinson
Opioids and the control of respiration
Br. J. Anaesth., June 1, 2008; 100(6): 747 - 758.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Walker, J. Paratz, and A. E. Holland
Reproducibility of the Negative Expiratory Pressure Technique in COPD
Chest, August 1, 2007; 132(2): 471 - 476.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. H. Manisty, K. Willson, R. Wensel, Z. I. Whinnett, J. E. Davies, W. L. G. Oldfield, J. Mayet, and D. P. Francis
Development of respiratory control instability in heart failure: a novel approach to dissect the pathophysiological mechanisms
J. Physiol., November 15, 2006; 577(1): 387 - 401.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Jack, H. B. Rossiter, M. G. Pearson, S. A. Ward, C. J. Warburton, and B. J. Whipp
Ventilatory Responses to Inhaled Carbon Dioxide, Hypoxia, and Exercise in Idiopathic Hyperventilation
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 118 - 125.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, and Pulmonary Function Testing in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 306 - 318.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. N. Bruce
Assessing Respiratory Control during Spontaneous Breathing . Practice May Be More Difficult than Theory
Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1033 - 1034.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van den Aardweg, J. G.
Right arrow Articles by Karemaker, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van den Aardweg, J. G.
Right arrow Articles by Karemaker, J. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society